Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/10884
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChympoy, K.A.-
dc.contributor.authorPashkovska, N.V.-
dc.contributor.authorFediv, O.I.-
dc.contributor.authorPavlibroda, N.M.-
dc.date.accessioned2016-05-26T09:35:39Z-
dc.date.available2016-05-26T09:35:39Z-
dc.date.issued2014-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/10884-
dc.description.abstractThe dynamics of the indices of fibrinolysis and cellular adhesion in patients with chronic diffuse liver diseases against the ground of administration of “Triovit”, a selenium-containing drug, has been studied. The administration of “Triovit” in a comprehensive therapy of patients with chronic diffuse liver diseases was found to improve the indices of the blood plasma fibrinolytic system, to reduce adhesive cellular properties and to increase total enzymatic activity of the blood plasma.ru_RU
dc.language.isoenru_RU
dc.publisherБуковинський медичний вісник. – 2014. – Т.18, №2(70). – C.113-116.ru_RU
dc.subjectchronic diffuse liver diseasesru_RU
dc.subjectcellular adhesionru_RU
dc.subjectfibrinolysisru_RU
dc.subjectTriovitru_RU
dc.subjectхронические диффузные заболевания печениru_RU
dc.subjectтиреоидный гомеостазru_RU
dc.subjectклеточная адгезияru_RU
dc.subjectфибринолизru_RU
dc.subjectтриовитru_RU
dc.subjectthyroid homeostasisru_RU
dc.subjectхронічні дифузні захворювання печінкиru_RU
dc.subjectтиреоїдний гомеостазru_RU
dc.subjectклітинна адгезіяru_RU
dc.subjectфібринолізru_RU
dc.subjectтриовітru_RU
dc.titlePathogenetic substantiation to correct disorders of the blood plasma fibrinolytic system in patients with chronic diffuse liverdiseases and disorders of thyroid homeostasisru_RU
dc.typeArticleru_RU
Appears in Collections:Статті. Кафедра клінічної імунології, алергології та ендокринології

Files in This Item:
File Description SizeFormat 
28.pdf448.01 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.